Related Experiment Video

Updated: May 5, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

24.2K

Treatment of left ventricular hypertrophy in hypertensive patients

J Tamargo1, E Delpón, C Valenzuela

  • 1Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.

European Heart Journal
|November 1, 1993
PubMed

Insights

Left ventricular hypertrophy (LVH) is a major cardiovascular risk. Certain antihypertensive drugs, especially ACE inhibitors, can reduce LV mass, improving diastolic function without harming systolic performance.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular morbidity and mortality.
  • Echocardiography and electrocardiography are key diagnostic tools for LVH.

Purpose of the Study:

  • To evaluate the impact of various antihypertensive drug classes on left ventricular mass.
  • To assess the potential of antihypertensive therapies to reverse LVH and improve cardiac function.

Main Methods:

  • Review of clinical studies on antihypertensive drug effects on LV mass.
  • Comparison of different drug classes including ACE inhibitors, beta-blockers, and calcium channel blockers.
  • Analysis of effects on both LV mass and cardiac performance (diastolic and systolic).

Main Results:

  • Antihypertensive drugs modulating sympathetic, renin-angiotensin-aldosterone systems, or intracellular calcium can reduce LV mass.
  • Angiotensin-converting enzyme (ACE) inhibitors show a pronounced effect in regression of LV mass.
  • Diuretics and vasodilators also regress LVH with long-term arterial pressure control.
  • Significant differences exist in LVH regression capabilities among drug classes and even within the same class.
  • Reduced LV mass is linked to improved diastolic function and no adverse effects on systolic performance.

Conclusions:

  • Antihypertensive therapy, particularly with ACE inhibitors, effectively reduces left ventricular mass in hypertensive patients.
  • Regression of LVH is associated with improved diastolic function and preserved systolic function.
  • Drug selection for hypertension management should consider LVH regression potential.

More Related Videos

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

2.5K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

965

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761